Lauren Pincus
Research interests are Cyberbiosecurity for Ag & Water, AI Assurance, and Green AI.
Arias Cardenas, Kelly C., Clinton W. Enos, Mark R. Spear, Dana E. Austin, Raghad Almofeez, Stephanie Kortchak, Lauren Pincus et al. "CT109-SN-38, a Novel Antibody-drug Conjugate with Dual Specificity for CEACAM5 and 6, Elicits Potent Killing of Pancreatic Cancer Cells." Current Cancer Drug Targets 24, no. 7 (2024): 720-732.
Pincus, Lauren, A. Raghad, M. Spear, D. Austin, K. Arias, and C. Gelber. "Identification of Nectin-4 Specific Monoclonal Antibodies Using a High-throughput Flow Cytometry Screening System." European Journal of Cancer 174 (2022): S90.
First place winner of NVTC Generative Impact AI Art Competition 2024. https://cyberinitiative.org/cci-news/2024-news/cci-professor-s-student-wins-ai-art-contest.html
First speaker for George Mason University at Howard Hughes Medical Institute (HHMI) 11th Annual SEA-PHAGES Symposium (Science Education Alliance-Phage Hunters Advancing Genomics and Evolutionary Science program). - June 2019. https://seaphages.org/abstracts/summary/552/